Primer: Cogstate Ltd (CGS AU) - Aug 2026
Cogstate is a leading neuroscience technology company specializing in digital cognitive assessments for clinical trials, particularly in...
87 Views
Aussie Healthcare Daily: 7 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
485 Views
Aussie Healthcare Daily: 5 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
288 Views
Taxing Times For Australia
The Government's release of Re:think, its tax discussion paper, is a welcome development, designed to kick-start the conversation with the...
6.1k Views
Cogstate - Donanemab Strikes Second ‘home Run’ for AD Drug Development
Eli Lilly has reported positive results from its Donanemab confirmatory phase 3 study, meeting both primary and secondary endpoints.
492 Views